Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 5 hrs 48 mins

S&P Futures
5,903.00
-3.00(-0.05%)
Dow Futures
43,546.00
+28.00(+0.06%)
Nasdaq Futures
20,446.50
-37.00(-0.18%)
Russell 2000 Futures
2,293.90
+2.70(+0.12%)
Crude Oil
69.67
+0.45(+0.65%)
Gold
2,740.90
+10.90(+0.40%)

Sagimet Biosciences Inc. (SGMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

5.41

+0.01

(+0.19%)

At close: 04:00PM EDT

5.40

-0.01

(-0.18%)

After hours:

07:57PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	174.18M
Enterprise Value	7.96M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	86.33
Price/Book (mrq)	0.95
Enterprise Value/Revenue	3.98
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	N/A
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	20.71
52 Week Low ³	2.13
50-Day Moving Average ³	3.41
200-Day Moving Average ³	4.88

Share Statistics

Avg Vol (3 month) ³	1.29M
Avg Vol (10 day) ³	905.18k
Shares Outstanding ⁵	30.67M
Implied Shares Outstanding ⁶	N/A
Float ⁸	16.2M
% Held by Insiders ¹	14.11%
% Held by Institutions ¹	70.16%
Shares Short (Sep 30, 2024) ⁴	1.97M
Short Ratio (Sep 30, 2024) ⁴	4.14
Short % of Float (Sep 30, 2024) ⁴	7.31%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	6.12%
Shares Short (prior month Aug 30, 2024) ⁴	1.86M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-1,813.75%

Management Effectiveness

Return on Assets (ttm)	-21.54%
Return on Equity (ttm)	-29.32%

Income Statement

Revenue (ttm)	2M
Revenue Per Share (ttm)	0.08
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	-29.25M
Diluted EPS (ttm)	-0.92
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	166.37M
Total Cash Per Share (mrq)	5.21
Total Debt (mrq)	153k
Total Debt/Equity (mrq)	0.08
Current Ratio (mrq)	29.11
Book Value Per Share (mrq)	5.74

Cash Flow Statement

Operating Cash Flow (ttm)	-22.8M
Levered Free Cash Flow (ttm)	-14.4M